Ciccarese, Chiara
 Distribuzione geografica
Continente #
EU - Europa 2.707
NA - Nord America 2.560
AS - Asia 1.900
SA - Sud America 247
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 7.491
Nazione #
US - Stati Uniti d'America 2.483
RU - Federazione Russa 1.050
SG - Singapore 692
GB - Regno Unito 651
CN - Cina 614
IT - Italia 254
BR - Brasile 184
SE - Svezia 182
VN - Vietnam 175
IE - Irlanda 147
HK - Hong Kong 143
DE - Germania 126
FR - Francia 113
KR - Corea 58
FI - Finlandia 53
BD - Bangladesh 41
IN - India 36
CA - Canada 35
AR - Argentina 29
MX - Messico 28
NL - Olanda 25
PL - Polonia 25
TR - Turchia 23
JP - Giappone 21
NG - Nigeria 20
ID - Indonesia 18
ZA - Sudafrica 15
ES - Italia 13
UA - Ucraina 13
EC - Ecuador 12
IQ - Iraq 12
MA - Marocco 11
BE - Belgio 9
AT - Austria 7
LT - Lituania 7
PH - Filippine 7
PK - Pakistan 7
VE - Venezuela 7
AZ - Azerbaigian 6
MY - Malesia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
KE - Kenya 5
PY - Paraguay 5
CH - Svizzera 4
EU - Europa 4
SA - Arabia Saudita 4
AL - Albania 3
CL - Cile 3
CO - Colombia 3
EG - Egitto 3
GR - Grecia 3
GT - Guatemala 3
JM - Giamaica 3
JO - Giordania 3
LK - Sri Lanka 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
BG - Bulgaria 2
CR - Costa Rica 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
NP - Nepal 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GH - Ghana 1
HN - Honduras 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MW - Malawi 1
NE - Niger 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.485
Città #
Southend 609
Singapore 358
Moscow 356
Ashburn 328
Chandler 300
San Jose 265
Dallas 175
Dublin 147
Beijing 144
Hong Kong 142
Woodbridge 105
The Dalles 98
Verona 75
Ann Arbor 74
Los Angeles 69
New York 61
Houston 60
Council Bluffs 52
Ho Chi Minh City 48
Lawrence 46
Princeton 46
Jacksonville 45
Nanjing 42
Wilmington 38
Hanoi 31
Jinan 31
São Paulo 31
Santa Clara 26
Shenyang 26
Montreal 22
Abuja 20
Buffalo 20
Redondo Beach 20
Columbus 19
Hebei 19
Denver 17
Munich 17
Tokyo 17
Helsinki 16
Tianjin 16
Changsha 15
Brooklyn 14
Milan 14
Redwood City 14
Dong Ket 13
Guangzhou 13
Haikou 13
Sindelfingen 13
Zhengzhou 13
Stockholm 12
Warsaw 12
Johannesburg 11
Jakarta 10
London 10
Mexico City 10
Orem 10
Seoul 10
Taizhou 10
Amsterdam 9
Da Nang 9
Frankfurt am Main 9
Jiaxing 9
Bologna 8
Brussels 8
Dearborn 8
Ningbo 8
Norwalk 8
Rome 8
Biên Hòa 7
Boston 7
Chennai 7
Dhaka 7
Fuzhou 7
Kent 7
Nanchang 7
Seattle 7
Vienna 7
Ankara 6
Baku 6
Campinas 6
Hangzhou 6
Lanzhou 6
Phoenix 6
San Francisco 6
Taiyuan 6
Tashkent 6
Turku 6
Chicago 5
Haiphong 5
Istanbul 5
Krakow 5
New Delhi 5
Paris 5
Atlanta 4
Bussolengo 4
Casablanca 4
Catanzaro 4
Fairfield 4
Falkenstein 4
Groningen 4
Totale 4.513
Nome #
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 249
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 232
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 216
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 216
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 212
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 203
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 201
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 194
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 191
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 191
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 189
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 187
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 187
Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research 186
AR-V7 and prostate cancer: The watershed for treatment selection? 180
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? 180
The development of PARP as a successful target for cancer therapy 177
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 175
Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis 174
2015 and human cancer: back to overall survival 171
Metabolic alterations in renal cell carcinoma 166
Metabolic phenotype of bladder cancer 165
The route to personalized medicine in bladder cancer: where do we stand? 164
Inside the 2015 ASCO Genitourinary Cancers Symposium 158
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 154
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer 153
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice 153
Metabolic Alterations in Renal and Prostate Cancer 150
Bladder cancer: molecular determinants of personalized therapy 150
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 149
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer 149
Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer 146
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 141
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies 140
Acquired hemophagocytic syndrome: comment to the case report 139
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives 130
Cabozantinib in Advanced Renal Cell Carcinoma: Is it a METEOR? 130
Kidney cancer and 2014: is innovation really over? 129
Emerging Immunotargets in Bladder Cancer 128
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis 122
Role of STAT3 pathway in genitourinary tumors 113
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 110
Tp53 and its potential therapeutic role as a target in bladder cancer 103
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 101
The prospect of precision therapy for renal cell carcinoma 91
PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate Cancer 91
Present and future of personalized medicine in adult genitourinary tumors 73
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 63
Totale 7.572
Categoria #
all - tutte 25.123
article - articoli 25.123
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/2022282 15 66 2 32 23 8 3 21 10 8 11 83
2022/2023827 54 96 72 136 59 221 2 62 93 11 17 4
2023/2024357 13 34 25 32 75 36 10 39 5 18 60 10
2024/20251.019 48 54 51 234 27 37 23 20 199 47 87 192
2025/20263.511 220 162 212 707 898 216 266 163 316 216 52 83
Totale 7.572